|
About the D-News category
|
|
0
|
654
|
March 31, 2017
|
|
FYI. Libre 3/Libre+ users
|
|
35
|
254
|
December 21, 2025
|
|
Why I don't believe most of the headlines on tech progress in diabetes technology
|
|
8
|
102
|
December 21, 2025
|
|
Non-invasive glucose monitoring from MIT
|
|
8
|
72
|
December 9, 2025
|
|
News from California
|
|
5
|
91
|
December 8, 2025
|
|
Dexcom Smart Basal for T2s
|
|
1
|
46
|
December 4, 2025
|
|
They are shutting down tu
|
|
58
|
582
|
November 20, 2025
|
|
New type of Diabetes (Type 5) recognized by the IDF
|
|
7
|
153
|
October 6, 2025
|
|
Proposed CMS changes that concern pump users
|
|
6
|
148
|
October 3, 2025
|
|
Type 5 Diabetes
|
|
5
|
86
|
October 2, 2025
|
|
Not a cure, but seems promising
|
|
8
|
207
|
September 12, 2025
|
|
Dissolvable pills for needle-free insulin delivery
|
|
2
|
70
|
July 21, 2025
|
|
New study opportunity
|
|
0
|
59
|
January 7, 2025
|
|
New Edition of Pumping Insulin Released
|
|
1
|
121
|
December 3, 2024
|
|
The story behind insulin pens
|
|
5
|
87
|
October 28, 2024
|
|
It’s one patient
|
|
11
|
161
|
October 11, 2024
|
|
Vertex clinical trials update
|
|
7
|
417
|
October 8, 2024
|
|
FDA approves new CGM that can be worn for a full year
|
|
12
|
285
|
October 7, 2024
|
|
Problem with Freestyle Libre 3 Sensors
|
|
1
|
63
|
July 26, 2024
|
|
A fresh look at diabetic ketoacidosis (DKA) guidelines
|
|
1
|
283
|
May 28, 2024
|
|
Research study on AID system focuses on teens
|
|
4
|
172
|
May 28, 2024
|
|
Article about the ADA promoting Sucralose overload?
|
|
22
|
564
|
May 16, 2024
|
|
T1D Exchange/Registry article on Hypoglycemia
|
|
3
|
129
|
May 8, 2024
|
|
New non-artificial but sugar-free sweetener just approved by FDA
|
|
1
|
249
|
March 26, 2024
|
|
OTC cgm approved for ppl who do not inject/pump insulin
|
|
15
|
501
|
March 8, 2024
|
|
Dexcom site is down
|
|
10
|
432
|
March 6, 2024
|
|
Varisoft infusion sets recalled - only some lot numbers
|
|
3
|
242
|
February 10, 2024
|
|
Tandem connectivity to G7 and Libre 2 Plus
|
|
2
|
337
|
January 10, 2024
|
|
FDA approves new T1D beta cell therapy
|
|
1
|
198
|
December 26, 2023
|
|
Novo Nordisk will phase out Levemir in 2024
|
|
11
|
381
|
December 12, 2023
|